Dr. Nicholas Reder is a board certified and award winning pathologist and the CEO and founder of Alpenglow Biosciences, Inc., a 3D spatial biology company. He received a BS in biochemistry from the University of Michigan, an MPH in epidemiology from Emory University, and an M.D. from Loyola University Chicago before receiving his pathology training at University of Washington, where he completed an anatomic pathology residency followed by a genitourinary pathology fellowship. While in residency, Dr. Reder won the Castleman Award, the highest honor for a pathologist under the age of 40. Dr. Reder has published more than 30 peer-reviewed journal articles and is a listed inventor on 5 patents (3 issued, 2 pending). Under his leadership, Alpenglow Biosciences has created a complete end-to-end solution to accelerate drug development including the 3D imager, 3D processing, and 3D analysis to provide deep insights into therapeutic efficacy, mechanism of action, and toxicity.
.svg)
